SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 58.00.
| Share Price | ₹796.5 | May 29,2026 |
| Market Cap | ₹1,768.2 Cr | |
| Earnings-TTM | ₹30.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 58.00x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,768.2 Cr] as on May 29,2026
(/) Earnings [ ₹30.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 58.00x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 58.00 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.38x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 26.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2022 of 15.24x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SAKAR HEALTHCARE | 30.49 | 58.00 | 1,768.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 37.36 | 432,096.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 68.85 | 176,807.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 69.56 | 148,718.0 |
| CIPLA LTD | 3,869.79 | 29.19 | 112,971.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.24 | 108,752.0 |
| MANKIND PHARMA LTD | 1,926.41 | 50.97 | 98,179.5 |
| LUPIN LTD | 5,355.47 | 19.40 | 103,900.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.57 | 108,442.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 23.51 | 82,330.8 |
| LAURUS LABS LTD | 889.85 | 82.61 | 73,506.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.40x |
| Max industry PE | 82.61x |
| Median industry PE | 37.36x |
| Average industry PE | 44.30x |
You may also like the below Video Courses